Illumina
Gene-Sequencing Company Illumina To Sell Cancer Test Developer – Beragampengetahuan
On Sunday, the premier maker of genome sequencing machines, Illumina, revealed its plan to offload Grail, a developer of cancer tests it had previously obtained for $7.1 billion in 2021. The decision was initiated two days post-Illumina suffering a loss in a federal appellate court case. The court majorly reinforced a ruling from the Federal […]